Andraz Perhavec

6PUBLICATIONS
62CO-AUTHORS
Predictive and prognostic markersOncology and carcinogenesis not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 21, 2026
Marking Techniques for Target Lymph Nodes in Node-Positive Breast Cancer Treated With Neoadjuvant Therapy in the AXSANA/EUBREAST-03/AGO-B-053 Study.

Maggie Banys-Paluchowski, Steffi Hartmann, Jana de Boniface

|May 30, 2025
Assessment of financial toxicity in patients with cancer in Slovenia.

Katja Vöröš, Marjeta Skubic, Mojca Bavdaž

|Apr 21, 2025
Financial Toxicity Among Cancer Patients in Slovenia.

Marjeta Skubic, Katja Vöröš, Mojca Bavdaž

|Nov 07, 2024
Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study.

Giacomo Montagna, Alison Laws, Massimo Ferrucci

|Sep 07, 2023
Absence of post-treatment changes in sentinel lymph nodes does not translate into increased regional recurrence rate in initially node-positive breast cancer patients.

Nina Pislar, Gorana Gasljevic, Ivica Ratosa

|Aug 27, 2021
Improved Survival after Breast-Conserving Therapy Compared with Mastectomy in Stage I-IIA Breast Cancer.

Ivica Ratosa, Gaber Plavc, Nina Pislar

Pageof 1

Frequent Collaborators

3 joint publications

Ivica Ratosa

2 joint publications

Helena Barbara Zobec Logar

2 joint publications

Petra Došenović Bonča

2 joint publications

Mojca Bavdaž